Clinical study on efficacy and safety of Huangqi Guizhi Wuwu decoction bubble bag in paclitaxel related peripheral neuritis of breast cancer patients : A protocol for a randomized, controlled, double-blind trial

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: control group:Routine nursing measures were given, that is, health education combined with vitamin E milk and vitamin B12 ointment.;Test group:On the basis of the control group, Huangqi Guizhi Wuwu decoction was used to soak hands and feet.; CONDITION: Breast Cancer PRIMARY OUTCOME: Evaluation scale of peripheral neurotoxicity of chemotherapeutic drugs (EORTC qlq‐cipn20);Mental state rating scale;Score of TCM syndrome integral quantitative scale (slefi); INCLUSION CRITERIA: ????????????????;???18‐70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,??????? ????????????????;???18‐70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,??????? (1) breast cancer patients confirmed by histology or pathology; ? Age 18‐70 years old; ? Plan to receive or have received paclitaxel drugs: including solvent paclitaxel, docetaxel, albumin paclitaxel, paclitaxel liposome; ? The estimated survival time is more than 3 months; ? It conforms to the category of syndrome differentiation and treatment of blood arthralgia in traditional Chinese medicine; The patient is unconscious and can communicate with normal language
Epistemonikos ID: 1ea15074aebd4c64128653f3ebd708ec1269d825
First added on: Aug 26, 2024